Clearmind Medicine (CMND) EBITDA Yield: History & Chart

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T13:31:02.872Z.

Stored calculation inputs

Calculation as of: 2026-10-06T13:31:02.872Z.

Quote observation: 2026-10-06T13:30:00.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-07-31: -8,810,622
Quote market capitalization: 1,093,738
Total debt · period ending 2026-07-31: 1,798,264
Cash · period ending 2026-07-31: 12,035,210

FMP input reference: 003104a745df447911be4c5a9e680832c7b19445192e606e8359fbce1df4db86

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

CMND EBITDA Yield Metrics

EBITDA YIELD

N/A

CMND Competitors' EBITDA Yield

CMND

Clearmind Medicine Inc.

Current

Market Cap

$1.09M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HKPD

Cellyan Biotechnology Co., Ltd

vs CMND

Market Cap

$1.13M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

JUNS

Jupiter Neurosciences, Inc.

vs CMND

Market Cap

$1.15M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMCC

IM Cannabis Corp.

vs CMND

Market Cap

$1.16M

EBITDA Yield

N/A

TTM Avg

8.30%

3Y Avg

8.30%

5Y Avg

8.30%

ASBP

Aspire Biopharma Holdings, Inc.

vs CMND

Market Cap

$1.01M

EBITDA Yield

N/A

TTM Avg

86.52%

3Y Avg

86.52%

5Y Avg

86.52%

BBLG

Bone Biologics Corporation

vs CMND

Market Cap

$897948.00

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GCTK

GlucoTrack, Inc.

vs CMND

Market Cap

$893920.00

EBITDA Yield

N/A

TTM Avg

0.07%

3Y Avg

0.06%

5Y Avg

0.06%

DCOY

Decoy Therapeutics Inc.

vs CMND

Market Cap

$877747.00

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ARTL

Artelo Biosciences, Inc.

vs CMND

Market Cap

$1.36M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BJDX

Bluejay Diagnostics, Inc.

vs CMND

Market Cap

$815044.00

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Clearmind Medicine Inc. (CMND)	$1.09M	N/A	N/A	N/A	N/A
Cellyan Biotechnology Co., Ltd (HKPD)vs ›	$1.13M	N/A	N/A	N/A	N/A
Jupiter Neurosciences, Inc. (JUNS)vs ›	$1.15M	N/A	N/A	N/A	N/A
IM Cannabis Corp. (IMCC)vs ›	$1.16M	N/A	8.30%	8.30%	8.30%
Aspire Biopharma Holdings, Inc. (ASBP)vs ›	$1.01M	N/A	86.52%	86.52%	86.52%
Bone Biologics Corporation (BBLG)vs ›	$897948.00	N/A	N/A	N/A	N/A
GlucoTrack, Inc. (GCTK)vs ›	$893920.00	N/A	0.07%	0.06%	0.06%
Decoy Therapeutics Inc. (DCOY)vs ›	$877747.00	N/A	N/A	N/A	N/A
Artelo Biosciences, Inc. (ARTL)vs ›	$1.36M	N/A	N/A	N/A	N/A
Bluejay Diagnostics, Inc. (BJDX)vs ›	$815044.00	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

CMND EBITDA Yield Metrics

CMND Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics